Characterization of an Unusual Severe Yellow Fever Outbreak in the Colombian Andean Region.

Authors

Alex Julián Forero-Delgadillo, Jeison Andrés Morales-Olivera, Paula O Narvaez-Ramirez, Natalia Sanabria-Herrera, Valeria Aguirre Gutierrez, Lina F Martinez-Lemus, Cristian C Serrano-Mayorga, Diana Catalina Ramírez-Reyes, Juan Diego Melo-Pedraza, Julián Celis-Guzmán, Gustavo González-Varona, Henry Robayo-Amortegui, Jessica María Forero, Erwin Hernandez, Ingrid G Bustos, Sara Duque, Esteban Garcia-Gallo, Luis F Reyes

Published in

Open forum infectious diseases. Volume 13. Issue 10. Pages ofag636. Epub Oct 21, 2026.

Abstract

Yellow fever (YF) reemerged in Colombia's Andean region during 2024-2025, outside the country's historically recognized endemic areas. We characterized critically ill adults admitted during this outbreak and described clinical features, organ dysfunction, supportive care, and in-hospital outcomes.
We conducted a prospective observational cohort study of consecutive adults with reverse transcription polymerase chain reaction (RT-PCR)-confirmed YF admitted to the national referral intensive care unit in Ibagué, Tolima, Colombia, from March through September 2025. Clinical, laboratory, complication, intervention, and outcome data were prospectively captured using a standardized case report form.
Sixty-one patients were analyzed; 22 died (36.1%). Non-survivors had lower platelet counts and fibrinogen and higher INR, aminotransferases, lactate dehydrogenase, and creatinine at ICU admission. Shock, acute kidney injury, acute respiratory distress syndrome, disseminated intravascular coagulation, and severe bleeding were more frequent among non-survivors. Prior YF vaccination was self-reported by 10 patients (16.4%).
Severe YF in this Andean outbreak was characterized by hepatic-coagulation abnormalities and multisystem organ dysfunction. The occurrence of critical illness outside historically recognized endemic areas supports surveillance and vaccination strategies that can adapt to changing epidemiological risk.

PMID:
42909258
Bibliographic data and abstract were imported from PubMed on 23 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.